Medicine and Engineering Join Forces to Restore Disfigured Faces
Patients who have suffered devastating facial injuries sometimes go to great lengths to hide themselves from public view. "I #39;ve had patients come to me weari...
By: VideosatNSF
Go here to read the rest:
Medicine and Engineering Join Forces to Restore Disfigured Faces - Video
Old Crow Medicine Show / Darius Rucker - Wagon Wheel (Cover by Tommy Miller)
Wagon Wheel was originally sketched by Bob Dylan and then made famous by The Old Crow Medicine Show at many a music festival like Bonnaroo and there #39;s now a ...
By: SteamyInTheCity
Link:
Old Crow Medicine Show / Darius Rucker - Wagon Wheel (Cover by Tommy Miller) - Video
Taco medicine prank call
It tasted like chimichangas.
By: 1020ManchesterUnited
Read more:
LAUGHTER IS BEST MEDICINE! (6.20.13 - Day 1512)
Shirts, Guitar pick necklaces, Hoodies http://ctfxcmerch.com Check out #PetsAtWork at http://puri.na/PaW its something we believe in and should be everywhere...
By: CTFxC
Excerpt from:
Posted on June 21, 2013, Friday
KUCHING: Pain medicine has now become the main mode of post-operative analgesia and is widely used in the management of cancer and chronic pain.
Relatively a new field in the country, it has grown by leaps and bounds in the past decade.
According to deputy director of Health Malaysia Dr Chin Zin Hing, anaesthesiologists are the main players in the delivery of healthcare, with the latest count of 361 anaesthesiologists at 51 hospitals, providing high quality medical care to patients.
The current evidence-based knowledge on pain medicine has formed the basis for the new Pain Management Handbook, recently published by the Medical Development Division, Ministry of Health (MOH).
It serves as a guide for pain team in the hospitals to treat patients suffering from all kinds of pains. With only 15 pain specialists and five trainees in our system currently, I commend your commitment and hard work especially with the recent introduction of acupuncture.
I hope more pain relieving techniques and newer drugs will be introduced in the future, he said.
He was representing the director-general of Health Malaysia Datuk Dr Noor Hisham Abdullah at the opening of the 12th Asian and Oceanic Society of Regional Anaesthesia (Aosra) and Pain Medicine Congress here yesterday.
A total of 952 delegates from over 27 countries are attending the congress held here from June 19 to 22.
It is jointly organised by the Malaysian Society of Anaesthesiologists, the College of Anaesthesiologists and the Malaysian Association for the Study of Pain.
Go here to read the rest:
‘Pain medicine now widely used for management of cancer, chronic pain’
SINGAPORE, June 20, 2013 /PRNewswire/ -- NeuroAiD, a stroke treatment based on Traditional Chinese Medicine, increases the odds of achieving a better functional outcome, according to research published online in the journal Stroke.
The CHIMES study is an academic international double-blind placebo-controlled clinical trial which included 1,100 patients from several countries who had suffered an ischemic stroke of intermediate severity within 72 hours, treated and monitored for 3 months. Researchers found that patients who were taking NeuroAiD at acute stage had an 11% increase in the odds of achieving independence in function and being able to perform daily activities at the end of three months. This effect was even greater when NeuroAiD was started beyond 48 hours after stroke onset, with an increase of 39%.
The odds ratio was the highest among recently completed stroke trials of neuroprotective agents. The benefit observed is clinically relevant and might have reached statistical significance with a larger sample size. In addition the study confirmed the excellent safety profile of NeuroAiD. Stroke survivors who were on NeuroAiD had fewer adverse events than those in the control group. Further studies will likely look into the benefits of longer duration of treatment.
Prof. Christopher Chen, neurologist at the National University of Singapore and the principal investigator of the CHIMES study, said the results looked very promising and suggested that the effectiveness of such herbal supplements could have a great impact on stroke management. "I think one thing which is very clear is that NeuroAiD is safe in acute stroke. A previous meta-analysis suggested that NeuroAiD is efficacious and safe in the chronic stage of stroke. Now the Chimes study has provided us with much more reliable data about the safety and efficacy of NeuroAiD in acute stroke. I think the CHIMES results are not only a step forward, but also a major achievement."
Occurring everytwo seconds, stroke is one of the leading causes of mortality and morbidity worldwide. Each year, 20 million people suffer from the devastating disease. However, there are only a few effective, generally accepted and specific treatments available, such as thrombolytic treatment for highly selected patients. Therefore, there is an increasing need for multi-modal therapies to help more patients recover quickly and effectively from stroke. Moleac, a Singapore based bio-pharma company, developed NeuroAiD to meet this need.
The large-scale investigator-initiated study is an independent initiative conducted by the CHIMES Society, an international partnership of key opinion leaders in neurology. It is among the first large-scale endeavours to investigate the use of a product from natural substances in reducing disability after an acute stroke in a rigorous manner.
Traditional Chinese Medicine (TCM) is used extensively in Asia to facilitate recovery after stroke and has become an increasingly important player in the global health system and economy.Recent rigorous medical studies conducted on some TCMs have confirmed that they have, among other properties, antioxidant and anti-inflammatory effects, which render them attractive options to be investigated for stroke recovery.
About MoleacTo address therapeutic gaps, Moleac has pioneered a new drug development approach, looking at sources of innovation from Traditional Medicines, hence shortening considerably drug development cycle time and investment to bring medicine to sufferers' unaddressed needs. Moleac's neurorestorative drug NeuroAiD reaches patients in more than 30 countries.
About CHIMES SocietyThe CHIMES Society is a unique international partnership which consists of an innovative academic industry collaboration with the objective to establish new stroke treatments. CHIMES is a Singaporean non-profit society founded by a group of experts in stroke and South-East Asian stroke clinicians interested to implement a research project:the NeuroAiD Efficacy on stroke recovery trial (CHIMES trial).
CHIMES Society is the recipient from a research grant from theNational Medical Research Council in Singapore (NMRC)which supports the implementation of CHIMES trial in Singapore.
View original post here:
Stroke Treatment Based on Traditional Chinese Medicine Increases Chances of Recovery
Dr. Garret FitzGerald has done fundamental research on how anti-inflammatory drugs affect the heart.
STORY HIGHLIGHTS
Philadelphia (CNN) -- Dr. Garret FitzGerald's career in medicine almost fell through because of a cockroach.
His big zoology exam at University College, Dublin, involved dissecting the mouth of a cockroach under a microscope. To his horror, one of the major components jumped out of his field of vision. "It's over," he thought.
But it wasn't. The exam proctor, whom he remembers looking like Helen of Troy, got down on her hands and knees to help. After about five minutes of searching, she emerged with the mouth part on her thumb.
"If she hadn't found it, I would not be a physician," he said. "It's these quirks of nature that lead you to what you do."
FitzGerald went on to show that low-dose aspirin could prevent cardiovascular disease. He recently shared the Grand Prix Scientifique from the Lefoulon-Delalande Foundation of the Institute of France, a 500,000 ($668,000) award. Last year he won Canada's top cardiovascular research prize, the Louis and Artur Lucian Award.
"Dr FitzGerald for the past 30 years has been one of the leaders in cardiovascular disease research," said Dr. Jacques Genest, Lucian Award chairman and cardiovascular researcher at McGill University Health Center. "He has (been) just like a surfer, perpetually riding the crest of the wave, and he hasn't come down yet."
Now a professor of medicine and pharmacology at the University of Pennsylvania School of Medicine, FitzGerald's work on the cardiovascular implications of pain medicines has resulted in therapies that save lives and improve the quality of life for millions of patients, said Dr. Sanjay Kaul, cardiologist at Cedars-Sinai Medical Center and professor at the University of California, Los Angeles, School of Medicine.
"He's fearless, he's passionate, he's curious, visionary, very, very, collaborative, and most important, he's very nurturing. In my opinion he's the real deal," Kaul said.
Read the original:
NEW YORK (MainStreet)For years, experts have been predicting the transition of primary care doctors away from high patient loads and low reimbursements from health insurers to the potentially more lucrative and less time-consuming practice of concierge medicine.
Concierge doctors provide same-day appointments and 24/7 direct cell phone access. The national average annual fee is $1,612 to $1,800, according to the American Academy of Private Physicians.
Not all of these doctors seem to be reaping the financial benefits. Rather, they're reducing their workload. The average annual income for all internists in the United States is $191,520, according to the Bureau of Labor Statistics. A recently released three-year analysis of concierge and direct primary care doctors by the Concierge Medicine Research Collective found that the doctors who they surveyed from December 2009 to December 2012 earned between $100,000 and $300,000 a year. However, concierge doctors generally have a cap of between 300 and 600 patients, much less than the typical 2,000-plus patient load.
But some of these concierge doctors do increase their income when they switch from a traditional practice to a concierge practice. Practices that use management companies with a concierge business model have less overhead and their doctors tend to earn more, according to Sarah K. Bloch, vice president of operations at Total Access Medical, which handles business dealings for seven doctors. Total Access Medical doctors earn between $200,000 and $475,000 annually, she says.
Some patients, too, are reaping the financial benefits of concierge medicine. Total Access Medical doctors charge patients between $2,000 and $2,800 annually but don't charge their insurance. Not only does that save the patients on co-pays or the percentage of the bill that they are responsible for paying, but it also can save on high premiums.
Bloch says that some of their patients lower their premium costs by a switching to a high deductible health insurance plan to cover visits to specialists, labs, and hospitalizations. The doctors or their support staff do the legwork to find the cheapest lab or medical facility in accordance with a patient's health insurance coverage, Bloch says. She and others say that patients, due to the additional time these physicians have to spend with them, have fewer emergency room visits and fewer visits to specialists, which she says means fewer repeat tests. These are all cost savings for patients, which Bloch says can exceed $7,000 annually.
Many concierge practices, however, do charge for office visits in addition to the annual fee that they charge patients. Others have different business models. A spokesperson for Diamond Physicians says its annual fee, which starts at $95 per month, covers the doctor's time. Any procedure, such as wart removal, is charged to insurance, which means patients must pay their deductibles and co-pays or coinsurance. However, there's still money to be saved in a practice like this. Uninsured patients are charged only 5% to 10% of the cost of the same procedure performed in an urgent care center or emergency room.
Further, others affiliated with concierge medicine of point out that for patients in professions that bill high hourly rates, such as attorneys, there's also a savings in time, because appointments at concierge practices typically run on time.
Whether or not the annual fee is tax deductible is a tricky question. It all depends on what the fee covers, which varies from practice to practice. Some business models use the fee for preventive tests, some use it for the doctor's time in making diagnoses, and some charge it as a premium for access into their concierge practice.
"The deductibility of a medical concierge -- either as a medical expense or under an HSA [health savings account] -- is highly dependent on the type of expense ... being deducted," says Vincenzo Villamena, a CPA and managing partner of the firm OnlineTaxman.com. "The real question is whether an expense is primarily for medical care or is merely beneficial to general health, such as a premium to get easy access to a doctor," he says.
See original here:
SEOUL, South Korea--(BUSINESS WIRE)--
The 8th ICTAM Organizing Committee -- in recent years interest for traditional medicine has been growing within academia. Traditional medicine includes Korean medicine, Chinese medicine, Indian medicine, Chiropractic and Homeopathy. Knowledge exchange in various traditional medicine fields has been actively done for decades, which also triggered a new plan for a symposium held in Korea about traditional medicine.
The 8th ICTAM (International Congress on Traditional Asian Medicine) hosted by IASTAM (International Association for the Study of Traditional Asian Medicine) will be held at Samsung Sancheong HRD Center from September 9 to 13 of 2013 in Korea.
IASTAM is an international organization promoting research and studies on traditional Asian medicines while respecting individual traditional medicine and the local characteristics of each Asian nation. Since the first international convention in Canberra of Australia in 1979, it has successfully held symposiums in a slew of nations such as Indonesia, India, Japan, Germany, America and Bhutan.
South Korea was chosen as a host country for the 8th ICTAM, which is broadly thanks to Koreas Donguibogam that was registered as an UNESCO World Documentary Heritage. The event will be held along with World Traditional Medicine Fair and Festival in Sancheong, KOREA 2013 commemorating the 400th year since the first publication of Donguibogam.
With the title Beyond integration: Reflections on Asian medicines in the 21st century, the symposium will feature academic events, exhibitions and official tours to Sancheong Fair and Festival. The event will be a good opportunity to closely look into the current integrative medicine zeal of the world and to discuss the essence and superiority of traditional medicine of each Asian nation.
The 8th ICTAM will include a clinical demonstration session in which traditional medicine clinicians from Korea and other nations will present clinical demonstrations. There will also be a post-conference optional program of tours to Korean Medicine clinics for clinicians and researchers from other nations.
Renowned scholars participating in the event include Volker Scheid who is the president of IASTAM, Asaf Goldschmidt, Florence Bretelle-Establet, Judith Farquhar, Marta Hanson, Narendra Bhatt, and Pei Shengji. Application for participation is available on ICTAMs official webpage. (www.iastam.org)
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130621005156/en/
Read more from the original source:
International Congress on Traditional Asian Medicine to Be Held in Korea, September 2013
NEW YORK, June 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Personalized Medicine Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment http://www.reportlinker.com/p01361264/Personalized-Medicine-Market---A-Strategic-Analysis-of-Industry-Trends-Technologies-Participants-and-Environment.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 239 tables & figures.
The personalized medicine (global) market is presented as follows:
By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)
A wealth of financial data & business strategy information is provided including:
Up-to-date company financials, sales & revenue figures Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies Business Model Strategies for Providers. Provider Systems and Academic Medical Centres Business Model Strategies for Payers & Governments Private and Public Funding and Personalized Medicine Reimbursement Revisions to Current Payment Systems and intellectual property How to Gain Market Penetration in the EU Cost-effectiveness and Business Value of Personalized Medicine Consumer genomics and POC market Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations) Comprehensive account of company product portfolios & kits
SWOT, Economic & Regulatory Environment specifics include:
Key strengths, weaknesses and threats influencing leading player position within the market Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing) Top fastest growing market segments and emerging opportunities Top pharmaceutical companies within the IPM by market share and revenue Comprehensive product portfolios, R&D activity and pipeline therapeutics M&A activity and future strategies of top personalized medicine pharmacos Personalized Medicine Regulation (UK, Germany, France, Spain, Italy) CE-marked Personalized Medicine/Diagnostic Tests FDA Advances in Personalized Medicine Regulation
This report highlights a number of significant Indian pharmacos and gives details of their operations, products, financials and business strategy.
View post:
DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/gfvrg9/personalized) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to their offering.
Personalized Medicine is often defined as the right treatment for the right person at the right time. Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industry.
Key Trends
By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.
By Diseases Segment - Personalized Medicine diagnostics market is expected to be more than US$ 30 Billion by 2018. Diabetes management test and Cancer management test are the leading market in this segment.
Renub Research report entitled Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market.
Key Topics Covered
1. Executive Summary
2. Worldwide Personalized Medicine Diagnostic Market & Forecast
Read the original:
BOCA RATON, FL--(Marketwired - Jun 21, 2013) - Modernizing Medicine, Inc.'s co-founder and Chief Medical Officer, Dr. Michael Sherling, has been named one of South Florida Business Journal's "40 Under 40" exemplary young executives for 2013. Dr. Sherling follows fellow co-founder and CEO, Daniel Cane, who made the "40 Under 40" list in 2012.
This tremendous achievement follows on the heels of Modernizing Medicine's recent award wins, including "Fastest Growing Company in South Florida" in 2012 and 2013 by the South Florida Business Journal, and Forbes' "America's Most Promising Companies" in 2013.
Modernizing Medicine was founded in 2010, when Dr. Sherling, a Yale and Harvard-trained board certified dermatologist, couldn't find an electronic medical record (EMR) system that worked for him.He then partnered with Cane, a serial software entrepreneur, to launch Modernizing Medicine, an electronic medical record and data company, and build a better EMR system.Modernizing Medicine's Electronic Medical Assistant (EMA) is built by doctors, for doctors.Currently, over 2,600 health providers in over 1,000 practices across the U.S. use EMA.
"With most EMR systems doctors have to spend all of their time typing or clicking boxes to input data, sacrificing valuable time with their patients," explains Dr. Sherling. "EMA brings touch technology to the bedside, allowing doctors to spend more time with their patients and their families.That makes doctors happy and that's why we have become so successful so quickly."
In addition to the EMR systems in dermatology, ophthalmology, optometry, orthopedics, plastic surgery and cosmetics, Modernizing Medicine is currently developing products for gastroenterology and otolaryngology (ENT).Recently, Modernizing Medicine launched EMA Outcomes, a revolutionary data analytics product, that tracks how a patient's disease or condition has changed over time.EMA visualizes a patient's data longitudinally presenting at a glance views of trends, treatments and outcomes.
"We're not just about being faster," Dr. Sherling says. "We're about being better."
Details about the '40 Under 40' and the full list of honorees are available on the South Florida Business Journal website.
About Modernizing MedicineModernizing Medicine is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Our product, Electronic Medical Assistant (EMA), is a cloud-based, specialty-specific electronic medical record (EMR) system with a massive library of built-in medical content, designed to save physicians time. Available as a native iPad application or from any web-enabled Mac or PC, EMA adapts to each provider's unique style of practice and is designed to interface with hundreds of different practice management systems.Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery markets, and to more than 1,000 physician practices across the country.In 2013 Modernizing Medicine was listed at No. 47 on FORBES annual ranking of America's Most Promising Companies.
See the original post:
BON JOVI - BAD MEDICINE - SUNDERLAND STADIUM OF LIGHT - JUNE 13 2013
Classic.
By: djheckford
See the rest here:
BON JOVI - BAD MEDICINE - SUNDERLAND STADIUM OF LIGHT - JUNE 13 2013 - Video
Bon Jovi Bad Medicine Sunderland Stadium of Light 13/06/2013
WP 20130613 006.
By: Slugbabydotcom
Read the rest here:
Bon Jovi Bad Medicine Sunderland Stadium of Light 13/06/2013 - Video
Elad Yom-Tov Microsoft - Learning About Medicine by Applying Machine Learning - Technion Lecture
Elad Yom-Tov of Microsoft - "Learning About Medicine by Applying Machine Learning to User Generated Content: The Case of Anorexia" Collecting medical informa...
By: Technion
Originally posted here:
Baseball at Faculty of Medicine Ainshams
By: Muhammed Akram
See the original post:
As They Burn - Medicine 2.0 (Live)
Music video by As They Burn performing Medicine 2.0 (Live). 2013 Victory Records.
By: AsTheyBurnVEVO
View post:
PCMH: Implementing an EHR System in a Paper Medicine Practice
A key component of the patient-centered medical home is the electronic health or medical record (EHR). Sharon Messics, MD, has successfully lead her practice...
By: Best Doctors
Original post:
PCMH: Implementing an EHR System in a Paper Medicine Practice - Video
Genomic Medicine at Work at Mayo Clinic
Mayo Clinic #39;s Individualized Medicine Clinic uses a person #39;s genomic information along with the latest in sequencing and careful expert analysis to diagnose ...
By: Mayo Clinic
Originally posted here:
Empathy Interview: Raul de Velasco Edwin Rutsch: How to Build a Culture of Empathy in Medicine
Video Transcripts and more at: http://cultureofempathy.com/References/Experts/others/Raul-de-Velasco.htm The Center for Building a Culture of Empathy http://...
By: Edwin Rutsch
More: